Table 1.
n | % | ||||
Age (years old) | |||||
<30 | 1 | 2.2 | |||
30–39 | 8 | 17.4 | |||
40–49 | 13 | 28.3 | |||
50–59 | 14 | 30.4 | |||
60–69 | 8 | 17.4 | |||
≥ 70 | 2 | 4.3 | |||
Recurrence | |||||
None | 27 | 58.7 | |||
Local recurrence | 11 | 17.4 | |||
Distant metastasis | 6 | 19.6 | |||
Peritoneal dissemination | 2 | 4.3 | |||
FIGO stage | |||||
IB | 22 | 47.8 | |||
IIA | 2 | 4.3 | |||
IIB | 9 | 19.6 | |||
IIIA | 1 | 2.2 | |||
IIIB | 7 | 15.2 | |||
IV | 5 | 10.9 | |||
Tumor size | |||||
< 40mm | 21 | 45.7 | |||
≥ 40mm | 23 | 50.0 | |||
Lymph node metastasis | |||||
Negative | 30 | 65.2 | |||
Positive | 10 | 21.7 | |||
Unknown | 6 | 13.0 | |||
Histological subtype | |||||
Mucinous adenocarcinoma | 20 | 43.4 | |||
Endocervical type | 17 | 37.0 | |||
Intestinal type | 3 | 6.5 | |||
Endometrioid adenocarcinoma | 16 | 34.8 | |||
Others | 5 | 10.8 | |||
Adenosquamous carcinoma | 5 | 10.8 | |||
Treatment procedure | |||||
Resection only | 13 | 28.3 | |||
Resection with neoadjuvant chemotherapy | 13 | 28.3 | |||
Resection with adjuvant therapy only | 13 | 28.3 | |||
Chemo-radiation therapy only | 5 | 10.9 | |||
Chemotherapy only | 2 | 4.3 |
FIGO, The International Federation of Gynecology and Obstetrics.